(S)-1-(2-(difluoromethyl)pyridin-4-yl)-4-fluoro-1-(3-(pyrimidin-5-yl)phenyl)-1H-isoindol-3-amine, 10mg

2-Imidazolidone, 97.00%, 1kg

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(1-(tert-butoxycarbonyl)-1H-indol-3-yl)-2-methylpropanoic acid, 95%, 50mg

Morpholino(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)methanone, 95.0%, 5g

N3-ethylpyridine-2,3-diamine, 98%, 1g

(3-Chloro-4-cyanophenyl)boronic acid, 95.0%, 10g

1H-Indol-4-yl acetate, 98.0%, 5g

4-(4-Chloro-phenylsulfanyl)-butyric acid, 95.0%, 1g

ethyl 1-ethylpiperidine-4-carboxylate, 95.0%, 25g

4-Chloro-3-(pyridin-2-yl)aniline, 95.0%, 100mg

(1-Phenylcyclopropyl)methanamine hydrochloride, 95.0%, 25g

ETHYL (2R,4R)-1-BOC-4-METHYL-5-OXOPYRROLIDINE-2-CARBOXYLATE, 95.0%, 1g

5-Bromo-6-hydroxy-1,3-benzodioxole>98.0%(HPLC)5g